Buyer Name: NHS England
Buyer Address: Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, United Kingdom
Contact Email: david.ford1@nhs.net
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
Buyer Contact Info
Status
complete
complete
Procedure
open
open
Value
160000000.0 GBP
160000000.0 GBP
Published
26 Feb 2026, 15:59
26 Feb 2026, 15:59
Deadline
n/a
n/a
Contract Start
31 Mar 2026, 23:00
31 Mar 2026, 23:00
Contract End
31 Mar 2028, 22:59
31 Mar 2028, 22:59
Category
n/a
n/a
CPV
33600000 - Pharmaceutical products
33600000 - Pharmaceutical products
Region
n/a
n/a
Awarded To
Abbvie Ltd, Gilead Sciences Limited
Abbvie Ltd, Gilead Sciences Limited
Official Source
Open Find a Tender
Open Find a Tender
Description
Project title: NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives commencing 1st April 2026 Offer reference number: CM/TNS/25/5737 Period of framework: 1 April 2026 to 31 March 2028 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Linked Documents
No linked documents found for this notice.
Opportunity Context
Lots
Lot 1 Status: complete
Awards
Award Title: NHS England procurement for the supply of pangenotypic Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
Raw Notice JSON
Expand raw payload
{
"awards": [
{
"aboveThreshold": true,
"assessmentSummariesDateSent": "2026-02-26T00:00:00Z",
"contractPeriod": {
"endDate": "2028-03-31T23:59:59+01:00",
"maxExtentDate": "2030-03-31T23:59:59+01:00",
"startDate": "2026-04-01T00:00:00+01:00"
},
"date": "2026-02-25T00:00:00Z",
"documents": [
{
"datePublished": "2026-02-26T15:59:34Z",
"description": "Contract award notice on Find a Tender",
"documentType": "awardNotice",
"format": "text/html",
"id": "017531-2026",
"noticeType": "UK6",
"url": "https://www.find-tender.service.gov.uk/Notice/017531-2026"
}
],
"hasOptions": true,
"hasRenewal": true,
"id": "1",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "goods",
"milestones": [
{
"dueDate": "2026-03-13T23:59:59Z",
"id": "1",
"status": "scheduled",
"type": "futureSignatureDate"
}
],
"options": {
"description": "Option or options to extend (at the Authority\u2019s discretion) for a period or periods up to a total of 24 months."
},
"relatedLots": [
"1"
],
"renewal": {
"description": "Option or options to extend (at the Authority\u2019s discretion) for a period or periods up to a total of 24 months."
},
"standstillPeriod": {
"endDate": "2026-03-09T23:59:59+00:00"
},
"status": "pending",
"suppliers": [
{
"id": "GB-PPON-PHRQ-1133-WGCH",
"name": "Abbvie Ltd"
},
{
"id": "GB-PPON-PPDW-8775-RCQV",
"name": "Gilead Sciences Limited"
}
],
"title": "NHS England procurement for the supply of pangenotypic Hepatitis C treatments and the provision of Hepatitis C elimination initiatives",
"value": {
"amount": 160000000.0,
"amountGross": 192000000.0,
"currency": "GBP"
}
}
],
"bids": {
"details": [
{
"id": "1",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-PPON-PHRQ-1133-WGCH",
"name": "Abbvie Ltd"
}
]
},
{
"id": "2",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-PPON-PPDW-8775-RCQV",
"name": "Gilead Sciences Limited"
}
]
}
],
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 2
},
{
"id": "2",
"measure": "finalStageBids",
"relatedLot": "1",
"value": 2
},
{
"id": "3",
"measure": "smeFinalStageBids",
"relatedLot": "1",
"value": 0
},
{
"id": "4",
"measure": "vcseFinalStageBids",
"relatedLot": "1",
"value": 0
}
]
},
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"date": "2026-02-26T15:59:34Z",
"id": "017531-2026",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-05cf3b",
"parties": [
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "SE1 8UG",
"region": "UKI45",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"contactPoint": {
"email": "david.ford1@nhs.net"
},
"details": {
"classifications": [
{
"description": "Public authority - central government",
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE"
}
],
"url": "https://www.england.nhs.uk/"
},
"id": "GB-PPON-PDPT-3135-BWWY",
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"name": "NHS England",
"roles": [
"buyer"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Maidenhead",
"postalCode": "SL6 4UB",
"region": "UKJ11",
"streetAddress": "Abbvie House Vanwall Business Park"
},
"contactPoint": {
"email": "carol.woodland@abbvie.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-PPON-PHRQ-1133-WGCH",
"identifier": {
"id": "PHRQ-1133-WGCH",
"scheme": "GB-PPON"
},
"name": "Abbvie Ltd",
"roles": [
"supplier",
"tenderer"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "WC1V 7EE",
"region": "UKI31",
"streetAddress": "280 High Holborn"
},
"contactPoint": {
"email": "uktenders@gilead.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-PPON-PPDW-8775-RCQV",
"identifier": {
"id": "PPDW-8775-RCQV",
"scheme": "GB-PPON"
},
"name": "Gilead Sciences Limited",
"roles": [
"supplier",
"tenderer"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"description": "Project title: NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives commencing 1st April 2026\nOffer reference number: CM/TNS/25/5737\nPeriod of framework: 1 April 2026 to 31 March 2028 with an option or options to extend (at the Authority\u0027s discretion) for a period or periods up to a total of 24 months.",
"id": "CM/TNS/25/5737",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"status": "complete",
"techniques": {
"hasFrameworkAgreement": true
},
"title": "NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives"
}
}